Venetoclax in relapsed or refractory chronic lymphocytic leukaemia with 17p deletion: a multicentre, open-label, phase 2 study-Reference-Cited by-同舟云学术

Venetoclax in relapsed or refractory chronic lymphocytic leukaemia with 17p deletion: a multicentre, open-label, phase 2 study

Published:2016-06 Issue:6 Volume:17 Page:768-778
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Stilgenbauer Stephan,Eichhorst Barbara,Schetelig Johannes,Coutre Steven,Seymour John F,Munir Talha,Puvvada Soham D,Wendtner Clemens-Martin,Roberts Andrew W,Jurczak Wojciech,Mulligan Stephen P,Böttcher Sebastian,Mobasher Mehrdad,Zhu Ming,Desai Monali,Chyla Brenda,Verdugo Maria,Enschede Sari Heitner,Cerri Elisa,Humerickhouse Rod,Gordon Gary,Hallek Michael,Wierda William G

Publisher

Elsevier BV

Subject

Oncology

Reference30 articles.

1. Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up;Eichhorst;Ann Oncol,2015

2. Therapeutic potential of new B cell-targeted agents in the treatment of elderly and unfit patients with chronic lymphocytic leukemia;Rai;J Hematol Oncol,2015

3. Mutations driving CLL and their evolution in progression and relapse;Landau;Nature,2015

4. Molecular pathogenesis of chronic lymphocytic leukemia;Gaidano;J Clin Invest,2012

5. Bendamustine combined with rituximab in patients with relapsed and/or refractory chronic lymphocytic leukemia: a multicenter phase II trial of the German Chronic Lymphocytic Leukemia Study Group;Fischer;J Clin Oncol,2011

Cited by 679 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of venetoclax in relapsed/refractory chronic lymphocytic leukemia in Russia routine clinical practice;Oncohematology;2024-09-01

2. Ibrutinib and venetoclax in combination for chronic lymphocytic leukemia: synergy in practice;Blood Neoplasia;2024-09

3. Holding the therapy in CLLp53: mechanisms to achieve durable responses;Anti-Cancer Drugs;2024-08-09

4. A phase 1 trial of venetoclax in combination with liposomal vincristine in patients with relapsed or refractory B‐cell or T‐cell acute lymphoblastic leukemia: Results from the ECOG‐ACRIN EA9152 protocol;eJHaem;2024-08-08

5. Impact of leukemia-associated macrophages on the progression and therapy response of chronic lymphocytic leukemia;Leukemia Research;2024-08